Metraipolis › archive › dc_49897bbebe4d

Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic… — Europe PMC PMID:42681619

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42681619
DOI
10.1186/s12885-[numero omesso]-9
License (as archived)
solo-consultazione
Archived
2026-10-18T03:13:16.956Z
SHA-256 of the archived text
31a2f00c33c9e218051769187fc57c825e5711cb283e39d83b465c3f3bb2480f
Stable URL of this page
https://metraipolis.com/documento/dc_49897bbebe4d

How to cite

Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic… — Europe PMC PMID:42681619 — Europe PMC (en), https://europepmc.org/article/MED/42681619 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_49897bbebe4d (Metraipolis archive dc_49897bbebe4d, sha256 31a2f00c33c9e218051769187fc57c825e5711cb283e39d83b465c3f3bb2480f)
BibTeX
@misc{dc49897bbebe4d,
  title = {Prognostic value of circulating tumor DNA and copy-number alterations in patients receiving tandem [225Ac]Ac-/[177Lu]Lu-PSMA-617 therapy for metastatic… — Europe PMC PMID:42681619},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42681619},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_49897bbebe4d; sha256 31a2f00c33c9e218051769187fc57c825e5711cb283e39d83b465c3f3bb2480f},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42681619. Agents can read the archived copy with the MCP tool read_document.